Testosterone Cypionate-Testosterone Propionate 180-20 mg/mL in… — Class II drug recall D-0944-2023
Ongoing recall by New Vitalis Pharmacy LLC dba New Vitalis Pharmacy, reported 2023-08-02, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0944-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | New Vitalis Pharmacy LLC dba New Vitalis Pharmacy, Louisville, KY, United States |
| Recall initiated | 2023-07-13 |
| Classified | 2023-07-24 |
| Reported by FDA | 2023-08-02 |
| Distributed | Nationwide (US) |
| Quantity | 102 vials |
| Reason classes | sterility |
| Expiration dates | 2023-07-22, 2023-08-11 |
Product
Testosterone Cypionate-Testosterone Propionate 180-20 mg/mL in cottonseed oil, Compounded Rx, For Intramuscular Use Only, a) 1 mL, b) 5 mL Multi-Dose Vial, New Vitalis Pharmacy, 4139 Cadillac Ct, Ste 201, Louisville, KY 40213
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0944-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.